Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review
Journal of Personalized Medicine · 17.09.2024 · 14 (9) · 990
DOI: 10.3390/jpm14090990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 17.09.2024. Verfasst von Ana Maria Dascalu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Age-related macular degeneration (AMD) is one of the main causes of blindness and visual impairment worldwide. Intravitreal complement inhibitors are an emergent approach in the treatment of AMD, which have had encouraging results. This systematic review analyzes the outcomes and safety of complement inhibitor therapies for GA in AMD cases.
Methods
A comprehensive search on the PubMed and Web of Science databases returned 18 studies involving various complement inhibitor agents, with a total of 4272 patients and a mean follow-up of 68.2 ± 20.4 weeks.
Results
Most treated patients were white (96.8%) and female (55.8%), with a mean age of 78.3 ± 7.8 years and a mean GA area of 8.0 ± 3.9 mm2. There were no differences in visual function change between treated and control participants. The mean GA area change was 2.4 ± 0.7 mm2 in treated participants vs. 2.7 ± 0.8 mm2 in control groups (p < 0.001). The ocular and systemic side effects were similar to those of intravitreal anti-VEGF. A less-understood effect was that of the onset of choroidal neovascularization (CNV) in 1.1–13% of patients; this effect was found to be more frequent in patients with neovascular AMD in the fellow eye or nonexudative CNV in the study eye at baseline.
Conclusions
Complement inhibitors may represent a useful therapy for GA in AMD, but a personalized approach to patient selection is necessary to optimize the outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Ophthalmology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania.
- Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.
- Fourth Surgery Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania.
- Faculty of Medicine, Ovidius University, 900470 Constanta, Romania.
- Ophthalmology Department, Emergency County Hospital Constanta, 900591 Constanta, Romania.
ORCID-Profile: Ana Maria Dascalu, Dragos Serban, Corneliu Tudor, Dan Dumitrescu, Dan Bratu
Zitieren
APA
Dascalu, A. M., Grigorescu, C. C., Serban, D., Tudor, C., Alexandrescu, C., Stana, D., Jurja, S., Costea, A. C., Alius, C., Tribus, L. C., Dumitrescu, D., Bratu, D., & Cristea, B. M. (2024). Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review. Journal of Personalized Medicine, 14(9), 990. https://doi.org/10.3390/jpm14090990
Vancouver
Dascalu AM, Grigorescu CC, Serban D, Tudor C, Alexandrescu C, Stana D, et al. Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review. Journal of Personalized Medicine. 2024;14(9):990. doi:10.3390/jpm14090990
BibTeX
@article{Dascalu2024,
author = {Dascalu, Ana Maria and Grigorescu, Catalin Cicerone and Serban, Dragos and Tudor, Corneliu and Alexandrescu, Cristina and Stana, Daniela and Jurja, Sanda and Costea, Andreea Cristina and Alius, Catalin and Tribus, Laura Carina and Dumitrescu, Dan and Bratu, Dan and Cristea, Bogdan Mihai},
title = {Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {9},
pages = {990},
doi = {10.3390/jpm14090990}
}
EUVIMED